Evidence Summaries The single deepest vertical pocket measurement in the assessment of amniotic fluid volume appears to be as effective as amniotic fluid index for preventing adverse pregnancy outcomes, and it appears to have a lower rate of obstetric intervention than amniotic fluid index.
A Cochrane review 1 included 5 studies with a total of 3,226 women with singleton pregnancies. There were no difference between amniotic fluid index (AFI) and single deepest vertical pocket (SDP) in the prevention of poor peripartum outcomes, including admission to a neonatal intensive care unit (RR 1.04, 95% CI 0.85 to 1.26; 5 trials, n=3,226); an umbilical artery pH of less than 7.1; the presence of meconium; an Apgar score of less than 7 at five minutes; or caesarean delivery. However, with AFI significantly more cases of oligohydramnios were diagnosed (RR 2.39, 95% CI 1.73 to 3.28; I2=59%), and more women had inductions of labor (RR 1.92, 95% CI 1.50 to 2.46) and caesarean delivery for fetal distress (RR 1.46, 95% CI 1.08 to 1.96).
A multicenter randomized controlled trial 2 included 1052 pregnant women with a term singleton pregnancy. Women were assigned randomly to AFI or SDP measurement for estimation of amniotic fluid volume. Oligohydramnios was defined as AFI ≤ 5 cm or the absence of a pocket measuring at least 2 × 1 cm. The diagnosis of oligohydramnios was followed by labor induction. Postpartum admission to a neonatal intensive care unit was similar between groups (4.2% [n = 21] vs 5.0% [n = 25]; RR 0.85, 95% CI 0.48 to1.50). In the AFI group, there were more cases of oligohydramnios (9.8% [n = 49] vs 2.2% [n = 11]; RR 4.51, 95% CI 2.2 to 8.57; P < 0.01) and more cases of labor induction for oligohydramnios (12.7% [n = 33] vs 3.6% [n = 10]; RR 3.50, 95% CI 1.76 to 6.96; P < 0.01) than in the SDP group. Moreover, an abnormal cardiotocography was seen more often in the AFI group than in the SDP group (32.3% [n = 161] vs 26.2% [n = 132]; RR 1.23, 95% CI 1.02 to 1.50; P = 0.03). The other outcome measures were not significantly different between the two groups.
Comment: The quality of evidence is downgraded by imprecise results (few outcome events).
. Nabhan AF, Abdelmoula YA. Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome. Cochrane Database Syst Rev 2008;(3):CD006593 [Review content assessed as up-to-date: 30 April 2009]. [PMID:18646160]
. Kehl S, Schelkle A, Thomas A et al. Single deepest vertical pocket or amniotic fluid index as evaluation test for predicting adverse pregnancy outcome (SAFE trial): a multicenter, open-label, randomized controlled trial. Ultrasound Obstet Gynecol 2016;47(6):674-9. [PMID:26094600]
Copyright © 2023 Duodecim Medical Publications Limited.
"Amniotic Fluid Index Versus Single Deepest Vertical Pocket as a Screening Test for Preventing Adverse Pregnancy Outcome." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456329/all/_________Amniotic_fluid_index_versus_single_deepest_vertical_pocket_as_a_screening_test_for_preventing_adverse_pregnancy_outcome______.
Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456329/all/_________Amniotic_fluid_index_versus_single_deepest_vertical_pocket_as_a_screening_test_for_preventing_adverse_pregnancy_outcome______. Accessed December 4, 2023.
Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456329/all/_________Amniotic_fluid_index_versus_single_deepest_vertical_pocket_as_a_screening_test_for_preventing_adverse_pregnancy_outcome______
Amniotic Fluid Index Versus Single Deepest Vertical Pocket as a Screening Test for Preventing Adverse Pregnancy Outcome [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 December 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456329/all/_________Amniotic_fluid_index_versus_single_deepest_vertical_pocket_as_a_screening_test_for_preventing_adverse_pregnancy_outcome______.
TY - ELEC
T1 - Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome
ID - 456329
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456329/all/_________Amniotic_fluid_index_versus_single_deepest_vertical_pocket_as_a_screening_test_for_preventing_adverse_pregnancy_outcome______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine